|
|
Blood, 15 May 2007, Vol. 109, No. 10, pp. 4306-4312.
Prepublished online as a Blood First Edition Paper on January 25, 2007; DOI 10.1182/blood-2006-09-047159.
Previous Article | Next Article 
Submitted September 13, 2006
Accepted January 17, 2007
NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome
Roi Gazit, Memet Aker, Moran Elboim, Hagit Achdout, Gil Katz, Dana Gila Wolf, Shulamit Katzav, and Ofer Mandelboim*
Lautenberg Center for General and Tumor Immunology, Hadassah Medical School, Jerusalem, Israel
Department of Pediatrics, Hadassah University Hospital, Jerusalem, Israel
Clinical Virology Unit, Dept of Clinical Microbiology & Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel
The Hubert H. Humphrey Center for Experimental Medicine, and Cancer Research, Hebrew University-Hadassah Medical School, Jerusalem, Israel
* Corresponding author; email: oferman{at}md2.huji.ac.il.
Griscelli Syndrome (GS) type 2 is an autosomal recessive disorder represented by pigment dilution and impaired CTL activity. NK activity has been scarcely investigated in GS patients. Here we describe a new patient, possessing a hemophagocytic syndrome with a homozygous Q118X nonsense RAB27A mutation. SSP-PCR was developed based on this mutation and is currently used in prenatal genetic analysis. As expected, CTLs in the patient are not functional and NK cytotoxicity against K562 or 721.221 cells is diminished. Surprisingly however, we demonstrate that CD16-mediated killing is intact in this patient and is therefore RAB27A-independent, whereas NKp30-mediated killing is impaired and is therefore RAB27A-dependent. We further analyzed the signaling pathways of these two receptors and demonstrated phosphorylation of Vav1 after CD16 activation, but not after NKp30 engagement. Thus, we identify a novel homozygous mutation in the RAB27A gene of a new GS patient, observe for the first time that some activating NK receptors function in GS patients and demonstrate a functional dichotomy in the killing mediated by these human NK activating receptors.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Wood, M. Meeths, S. C. C. Chiang, A. G. Bechensteen, J. J. Boelens, C. Heilmann, H. Horiuchi, S. Rosthoj, O. Rutynowska, J. Winiarski, et al.
Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity
Blood,
November 5, 2009;
114(19):
4117 - 4127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pachlopnik Schmid, D. Moshous, N. Boddaert, B. Neven, L. Dal Cortivo, M. Tardieu, M. Cavazzana-Calvo, S. Blanche, G. de Saint Basile, and A. Fischer
Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a single-center report on 10 patients
Blood,
July 2, 2009;
114(1):
211 - 218.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|